Stem Cell Therapies in Clinical Trials: Progress and Challenges

Cell Stem Cell

Volumn 17, Issue 1, 2015, Pages 11-22

  Trounson, Alan ^a   McDonald, Courtney ^a  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMNIOTIC FLUID CELL; AMYOTROPHIC LATERAL SCLEROSIS; ANIRIDIA; BRAIN ISCHEMIA; CANCER THERAPY; CELL TRANSFORMATION; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; CROHN DISEASE; DIABETES MELLITUS; ENDOTHELIAL PROGENITOR CELL; EPITHELIZATION; GEOGRAPHIC ATROPHY; GLIOBLASTOMA; GRAFT VERSUS HOST REACTION; HEART MUSCLE INJURY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIMBAL STEM CELL TRANSPLANTATION; LIVER DISEASE; LOW BACK PAIN; LUNG DISEASE; LUNG FIBROSIS; MACULAR DEGENERATION; MULTIPLE SCLEROSIS; MULTIPOTENT STEM CELL; NEURAL STEM CELL; NEURAL STEM CELL TRANSPLANTATION; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; OSTEOARTHRITIS; PANCREAS ISLET BETA CELL; PARKINSON DISEASE; PELIZAEUS MERZBACHER DISEASE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PLACENTA; PLACENTAL STEM CELL; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGULATORY T LYMPHOCYTE; RESPIRATORY TRACT DISEASE; RETINA DEGENERATION; REVIEW; SPINAL CORD INJURY; SPINAL CORD REGENERATION; STARGARDT DISEASE; STEM CELL TRANSPLANTATION; STEVENS JOHNSON SYNDROME; TREATMENT FAILURE; ADVERSE EFFECTS; CORNEA LIMBUS; CYTOLOGY; ENDOTHELIUM CELL; FEMALE; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; PREGNANCY; PROCEDURES; REGENERATIVE MEDICINE; STROKE; TRANSPLANTATION; TRENDS;

CLINICAL TRIALS AS TOPIC; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOSUPPRESSION; LIMBUS CORNEAE; LIVER DISEASES; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOCARDIAL INFARCTION; NEURAL STEM CELLS; OSTEOARTHRITIS; PLACENTA; PLURIPOTENT STEM CELLS; PREGNANCY; REGENERATIVE MEDICINE; STEM CELL TRANSPLANTATION; STROKE; TREATMENT FAILURE;

EID: 84936998148     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2015.06.007     Document Type: Review

References (115)

1. Abbott, A. (2014). Fetal-cell revival for Parkinson's. Nature 510, 195-196.
2. Aboody, K.S., Brown, A., Rainov, N.G., Bower, K.A., Liu, S., Yang, W., Small, J.E., Herrlinger, U., Ourednik, V., Black, P.M., et al. (2000). Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracra-nial gliomas. Proc. Natl. Acad. Sci. USA 97, 12846-12851.
3. Aboody, K.S., Najbauer, J., Metz, M.Z., D'Apuzzo, M., Gutova, M., Annala, A.J., Synold, T.W., Couture, L.A., Blanchard, S., Moats, R.A., et al. (2013). Neural stem cell-mediated enzyme/prodrug therapy for glioma: preclinical studies. Sci. Transl. Med. 5, 184ra159.
4. Ascheim, D.D., Gelijns, A.C., Goldstein, D., Moye, L.A., Smedira, N., Lee, S., Klodell, C.T., Szady, A., Parides, M.K., Jeffries, N.O., et al. (2014). Mesen-chymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices. Circulation 129, 2287-2296.
5. Averyanov, A. (2014). https://clinicaltrials.gov/ct2/show/NCT02326662.
6. Barker, R.A. (2014). Developing stem cell therapies for Parkinson's disease: waiting until the time is right. Cell Stem Cell 15, 539-542.
7. Bartunek, J., Behfar, A., Dolatabadi, D., Vanderheyden, M., Ostojic, M., Dens, J., El Nakadi, B., Banovic, M., Beleslin, B., Vrolix, M., et al. (2013). Cardio-poietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J. Am. Coll. Cardiol. 61, 2329-2338.
8. Bernardo, M.E., and Fibbe, W.E. (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13, 392-402.
9. Bersenev, A. (2015). Cell therapy clinical trials-2014 report. CellTrials blog, January 22, 2015. http://celltrials.info/2015/01/22/2014-report/.
10. Bianco, P. (2014). "Mesenchymal" stem cells. Annu. Rev. Cell Dev. Biol. 30, 677-704.
11. Bonab, M.M., Sahraian, M.A., Aghsaie, A., Karvigh, S.A., Hosseinian, S.M., Nikbin, B., Lotfi, J., Khorramnia, S., Motamed, M.R., Togha, M., et al. (2012). Autologous mesenchymal stem cell therapy in progressive multiple sclerosis: an open label study. Curr. Stem Cell Res. Ther. 7, 407-414.
12. Burillon, C., Huot, L., Justin, V., Nataf, S., Chapuis, F., Decullier, E., and Dam-our, O. (2012). Cultured autologous oral mucosal epithelial cell sheet (CAOMECS) transplantation for the treatment of corneal limbal epithelial stem cell deficiency. Invest. Ophthalmol. Vis. Sci. 53, 1325-1331.
13. CapricorTherapeutics (2015). http://capricor.com/clinical-trials/allstar/.
14. Chambers, D.C., Enever, D., Ilic, N., Sparks, L., Whitelaw, K., Ayres, J., Yerko-vich, S.T., Khalil, D., Atkinson, K.M., and Hopkins, P.M. (2014). A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idio-pathic pulmonary fibrosis. Respirology 19, 1013-1018.
15. Chang, Y.S., Ahn, S.Y., Yoo, H.S., Sung, S.I., Choi, S.J., Oh, W.I., and Park, W.S. (2014). Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J. Pediatr. 164, 966-972.e966.
16. Chen, H.C., Chen, H.L., Lai, J.Y., Chen, C.C., Tsai, Y.J., Kuo, M.T., Chu, P.H., Sun, C.C., Chen, J.K., and Ma, D.H. (2009). Persistence of transplanted oral mucosal epithelial cells in human cornea. Invest. Ophthalmol. Vis. Sci. 50, 4660-4668.
17. CIRM. (2013). Cell therapies for Parkinson's Disease from Discovery to Clinic. Californian Institute for Regenerative Medicine Workshop Report. http://www.cirm.ca.gov/sites/default/files/files/about-cirm/PD-Workshop- WP--10-10-13.pdf.
18. Connick, P., Kolappan, M., Crawley, C., Webber, D.J., Patani, R., Michell, A.W., Du, M.Q., Luan, S.L., Altmann, D.R., Thompson, A.J., et al. (2012). Autol-ogous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study. Lancet Neurol. 11, 150-156.
19. Cuenca, N., Fernández-Sánchez, L., McGill, T.J., Lu, B., Wang, S., Lund, R., Huhn, S., and Capela, A. (2013). Phagocytosis of photoreceptor outer segments by transplanted human neural stem cells as a neuroprotective mechanism in retinal degeneration. Invest. Ophthalmol. Vis. Sci. 54, 6745-6756.
20. Cyranoski, D. (2014). Japanese woman is first recipient of next-generation stem cells. Nature News (Nature Publishing Group), September 12, 2014. http://www.nature.com/news/japanese-woman-is-first-recipient-of-next-generation-stem-cells-1.15915.
21. Díez-Tejedor, E., Gutiérrez-Fernández, M., Martínez-Sánchez, P., Rodríguez-Frutos, B., Ruiz-Ares, G., Lara, M.L., and Gimeno, B.F. (2014). Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue: a safety assessment: a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial. J. Stroke Cerebrovasc. Dis. 23, 2694-2700.
22. Dimmeler, S., Ding, S., Rando, T.A., and Trounson, A. (2014). Translational strategies and challenges in regenerative medicine. Nat. Med. 20, 814-821.
23. Dlouhy, B.J., Awe, O., Rao, R.C., Kirby, P.A., and Hitchon, P.W. (2014). Auto-graft-derived spinal cord mass following olfactory mucosal cell transplantation in a spinal cord injury patient: Case report. J. Neurosurg. Spine 21, 618-622.
24. Duijvestein, M., Vos, A.C., Roelofs, H., Wildenberg, M.E., Wendrich, B.B., Ver-spaget, H.W., Kooy-Winkelaar, E.M., Koning, F., Zwaginga, J.J., Fidder, H.H., et al. (2010). Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study. Gut 59, 1662-1669.
25. El-Ansary, M., Abdel-Aziz, I., Mogawer, S., Abdel-Hamid, S., Hammam, O., Teaema, S., and Wahdan, M. (2012). Phase II trial: undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis. Stem Cell Rev. 8, 972-981.
26. European Medicines Agency. (2015). http://www.ema.europa.eu/ema/index. jsp?curl=pages/news-and-events/news/2014/12/news-detail-002239.jsp&mid=WC0b01ac058004d5c1.
27. Feldman, E.L., Boulis, N.M., Hur, J., Johe, K., Rutkove, S.B., Federici, T., Polak, M., Bordeau, J., Sakowski, S.A., and Glass, J.D. (2014). Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes. Ann. Neurol. 75, 363-373.
28. FierceBiotech. (2015) http://www.fiercebiotech.com/story/athersys-tanks-its-stem-cell-therapy-flunks-phase-ii-stroke-trial/2015-04-17.
29. Forbes, G.M., Sturm, M.J., Leong, R.W., Sparrow, M.P., Segarajasingam, D., Cummins, A.G., Phillips, M., and Herrmann, R.P. (2014). A phase 2 study of allogeneic mesenchymal stromal cells for luminal Crohn's disease refractory to biologic therapy. Clin. Gastroenterol. Hepatol. 12, 64-71.
30. Glass, J.D., Boulis, N.M., Johe, K., Rutkove, S.B., Federici, T., Polak, M., Kelly, C., and Feldman, E.L. (2012). Lumbar intraspinal injection of neural stem cells in patients with amyotrophic lateral sclerosis: results of a phase I trial in 12 patients. Stem Cells 30, 1144-1151.
31. Glenn, J.D., and Whartenby, K.A. (2014). Mesenchymal stem cells: Emerging mechanisms of immunomodulation and therapy. World J Stem Cells 6, 526-539.
32. Graw, J. (2010). Eye development. Curr. Top. Dev. Biol. 90, 343-386.
33. Grealish, S., Diguet, E., Kirkeby, A., Mattsson, B., Heuer, A., Bramoulle, Y., Van Camp, N., Perrier, A.L., Hantraye, P., Björklund, A., and Parmar, M. (2014). Human ESC-derived dopamine neurons show similar preclinical efficacy and potency to fetal neurons when grafted in a rat model of Parkinson's disease. Cell Stem Cell 15, 653-665.
34. Gupta, N., Henry, R.G., Strober, J., Kang, S.M., Lim, D.A., Bucci, M., Caver-zasi, E., Gaetano, L., Mandelli, M.L., Ryan, T., et al. (2012). Neural stem cell engraftment and myelination inthe human brain. Sci. Transl. Med. 4, 155ra137.
35. Gupta, P.K., Chullikana, A., Parakh, R., Desai, S., Das, A., Gottipamula, S., Krishnamurthy, S., Anthony, N., Pherwani, A., and Majumdar, A.S. (2013). A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia. J. Transl. Med. 11, 143.
36. Gyöngyösi, M., Wojakowski, W., Lemarchand, P., Lunde, K., Tendera, M., Bar-tunek, J., Marban, E., Assmus, B., Henry, T.D., Traverse, J.H., et al.; ACCRUE Investigators (2015). Meta-Analysis of Cell-based CaRdiac stUdiEs (ACCRUE) in patients with acute myocardial infarction based on individual patient data. Circ. Res. 116, 1346-1360.
37. Hare, J.M., Traverse, J.H., Henry, T.D., Dib, N., Strumpf, R.K., Schulman, S.P., Gerstenblith, G., DeMaria, A.N., Denktas, A.E., Gammon, R.S., et al. (2009). A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54, 2277-2286.
38. Hare, J.M., Fishman, J.E., Gerstenblith, G., DiFede Velazquez, D.L., Zam-brano, J.P., Suncion, V.Y., Tracy, M., Ghersin, E., Johnston, P.V., Brinker, J.A., et al. (2012). Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 308, 2369-2379.
39. Heldman, A.W., DiFede, D.L., Fishman, J.E., Zambrano, J.P., Trachtenberg, B.H., Karantalis, V., Mushtaq, M., Williams, A.R., Suncion, V.Y., McNiece, I.K., et al. (2014). Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial. JAMA 311, 62-73.
40. Herrmann, R., Sturm, M., Shaw, K., Purtill, D., Cooney, J., Wright, M., Phillips, M., and Cannell, P. (2012). Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease: a phase 1 study. Int. J. Hematol. 95, 182-188.
41. Hess, D.C., Sila, C.A., Furlan, A.J., Wechsler, L.R., Switzer, J.A., and Mays, R.W. (2014). A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke. Int. J. Stroke 9, 381-386.
42. Hirmand, S. (2014). Neural stem cells: On the frontier of brain cancer therapy. City of Hope: Breakthroughs, September 29, 2014. http://breakthroughs. cityofhope.org/neural-stem-cells-karen-aboody-jana-portnow.
43. Hong, S.H., Lee, H.J., An, J., Lim, I., Borlongan, C., Aboody, K.S., and Kim, S.U. (2013). Human neural stem cells expressing carboxyl esterase target and inhibit tumor growth of lung cancer brain metastases. Cancer Gene Ther. 20, 678-682.
44. Huo, W., Liu, X., Tan, C., Han, Y., Kang, C., Quan, W., and Chen, J. (2014). Stem cell transplantation for treating stroke: status, trends and development. Neural Regen Res 9, 1643-1648.
45. Introna, M., Lucchini, G., Dander, E., Galimberti, S., Rovelli, A., Balduzzi, A., Longoni, D., Pavan, F., Masciocchi, F., Algarotti, A., et al. (2014). Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol. Blood Marrow Transplant. 20, 375-381.
46. ISCO (2015). http://www.marketwired.com/press-release/international-stem-cell-corporation-conduct-parkinsons-disease-clinical-study-australia-otcqb-isco-1987126.htm.
47. Jang, Y.O., Kim, Y.J., Baik, S.K., Kim, M.Y., Eom, Y.W., Cho, M.Y., Park, H.J., Park, S.Y., Kim, B.R., Kim, J.W., et al. (2014). Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study. Liver Int. 34, 33-41.
48. + progenitor cells to promote angiogenesis in patients with refractory angina: final results of the PROGENITOR randomized trial. Circ. Res. 115, 950-960.
49. Karussis, D., Karageorgiou, C., Vaknin-Dembinsky, A., Gowda-Kurkalli, B., Gomori, J.M., Kassis, I., Bulte, J.W., Petrou, P., Ben-Hur, T., Abramsky, O., and Slavin, S. (2010). Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 67, 1187-1194.
50. Kawamoto, A., Katayama, M., Handa, N., Kinoshita, M., Takano, H., Horii, M., Sadamoto, K., Yokoyama, A., Yamanaka, T., Onodera, R., et al. (2009). Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 27, 2857-2864.
51. Kharaziha, P., Hellström, P.M., Noorinayer, B., Farzaneh, F., Aghajani, K., Jafari, F., Telkabadi, M., Atashi, A., Honardoost, M., Zali, M.R., and Soleimani, M. (2009). Improvement of liver function in liver cirrhosis patients after autolo-gous mesenchymal stem cell injection: a phase I-II clinical trial. Eur. J. Gastro-enterol. Hepatol. 21, 1199-1205.
52. Kinoshita, M., Fujita, Y., Katayama, M., Baba, R., Shibakawa, M., Yoshikawa, K., Katakami, N., Furukawa, Y., Tsukie, T., Nagano, T., et al. (2012). Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia. Atherosclerosis 224, 440-445.
53. Kolli, S., Ahmad, S., Lako, M., and Figueiredo, F. (2010). Successful clinical implementation of corneal epithelial stem cell therapy for treatment of unilateral limbal stem cell deficiency. Stem Cells 28, 597-610.
54. Konomi, K., Tobita, M., Kimura, K., and Sato, D. (2015). New Japanese initiatives on stem cell therapies. Cell Stem Cell 16, 350-352.
55. Kushner, J.A., MacDonald, P.E., and Atkinson, M.A. (2014). Stem cells to insulin secreting cells: two steps forward and now a time to pause? Cell Stem Cell 15, 535-536.
56. Kuzmina, L.A., Petinati, N.A., Parovichnikova, E.N., Lubimova, L.S., Griba-nova, E.O., Gaponova, T.V., Shipounova, I.N., Zhironkina, O.A., Bigildeev, A.E., Svinareva, D.A., et al. (2012). Multipotent Mesenchymal Stromal Cells for the Prophylaxis of Acute Graft-versus-Host Disease-A Phase II Study. Stem Cells Int. 2012, 968213.
57. Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M.E., Remberger, M., et al.; Developmental Committee of the European Group for Blood and Marrow Transplantation (2008). Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371, 1579-1586.
58. Lee, H.J., Kim, K.S., Ahn, J., Bae, H.M., Lim, I., and Kim, S.U. (2014a). Human motor neurons generated from neural stem cells delay clinical onset and prolong life in ALS mouse model. PLoS ONE 9, e97518.
59. Lee, J.W., Lee, S.H., Youn, Y.J., Ahn, M.S., Kim, J.Y., Yoo, B.S., Yoon, J., Kwon, W., Hong, I.S., Lee, K., et al. (2014b). A randomized, open-label, multi-center trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction. J. Korean Med. Sci. 29, 23-31.
60. Li, T.S., Cheng, K., Malliaras, K., Smith, R.R., Zhang, Y., Sun, B., Matsushita, N., Blusztajn, A., Terrovitis, J., Kusuoka, H., et al. (2012). Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J. Am. Coll. Cardiol. 59, 942-953.
61. Li, C., Dong, N., Wu, H., Dong, F., Xu, Y., Du, H., He, H., Liu, Z., and Li, W. (2013). A novel method for preservation of human corneal limbal tissue. Invest. Ophthalmol. Vis. Sci. 54, 4041-4047.
62. Liebergall, M., Schroeder, J., Mosheiff, R., Gazit, Z., Yoram, Z., Rasooly, L., Daskal, A., Khoury, A., Weil, Y., and Beyth, S. (2013). Stem cell-based therapy for prevention of delayed fracture union:arandomized and prospective preliminary study. Mol. Ther. 21, 1631-1638.
63. Lim, R., Chan, S.T., Tan, J.L., Mockler, J.C., Murphy, S.V., and Wallace, E.M. (2013). Preterm human amnion epithelial cells have limited reparative potential. Placenta 34, 486-492.
64. Liu, K., Chen, Y., Zeng, Y., Xu, L., Liu, D., Chen, H., Zhang, X., Han, W., Wang, Y., Zhao, T., et al. (2011). Coinfusion of mesenchymal stromal cells facilitates platelet recovery without increasing leukemia recurrence in haploidentical hematopoietic stem cell transplantation: a randomized, controlled clinical study. Stem Cells Dev. 20, 1679-1685.
65. Liu, X., Zheng, P., Wang, X., Dai, G., Cheng, H., Zhang, Z., Hua, R., Niu, X., Shi, J., and An, Y. (2014). A preliminary evaluation of efficacy and safety of Wharton's jelly mesenchymal stem cell transplantation in patients with type 2 diabetes mellitus. Stem Cell Res Ther 5, 57.
66. Llufriu, S., Sepúlveda, M., Blanco, Y., Marín, P., Moreno, B., Berenguer, J., Gabilondo, I., Martínez-Heras, E., Sola-Valls, N., Arnaiz, J.A., et al. (2014). Randomized placebo-controlled phase II trial of autologous mesenchymal stem cells in multiple sclerosis. PLoS ONE 9, e113936.
67. Logan, A.C., Weissman, I.L., and Shizuru, J.A. (2012). The road to purified hematopoietic stem cell transplants is paved with antibodies. Curr. Opin. Immunol. 24, 640-648.
68. Lublin, F.D., Bowen, J.D., Huddlestone, J., Kremenchutzky, M., Carpenter, A., Corboy, J.R., Freedman, M.S., Krupp, L., Paulo, C., Hariri, R.J., and Fischkoff, S.A. (2014). Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study. Mult. Scler. Relat. Disord. 3, 696-704.
69. Maldonado, G.E., Pérez, C.A., Covarrubias, E.E., Cabriales, S.A., Leyva, L.A., Pérez, J.C., and Almaguer, D.G. (2011). Autologous stem cells for the treatment of post-mastectomy lymphedema: a pilot study. Cytotherapy 13, 1249-1255.
70. Mayer, L., Pandak, W.M., Melmed, G.Y., Hanauer, S.B., Johnson, K., Payne, D., Faleck, H., Hariri, R.J., and Fischkoff, S.A. (2013). Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn's disease: a phase 1 study. Inflamm. Bowel Dis. 19, 754-760.
71. Maziarz, R.T., Devos, T., Bachier, C.R., Goldstein, S.C., Leis, J.F., Devine, S.M., Meyers, G., Gajewski, J.L., Maertens, J., Deans, R.J., et al. (2015). Single and multiple dose MultiStem (multipotent adult progenitor cell) therapy prophylaxis of acute graft-versus-host disease in myeloablative allogeneic hematopoietic cell transplantation: a phase 1 trial. Biol. Blood Marrow Transplant. 21, 720-728.
72. Mazzini, L., Ferrero, I., Luparello, V., Rustichelli, D., Gunetti, M., Mareschi, K., Testa, L., Stecco, A., Tarletti, R., Miglioretti, M., et al. (2010). Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: A Phase I clinical trial. Exp. Neurol. 223, 229-237.
73. Mazzini, L., Mareschi, K., Ferrero, I., Miglioretti, M., Stecco, A., Servo, S., Carriero, A., Monaco, F., and Fagioli, F. (2012). Mesenchymal stromal cell transplantation in amyotrophic lateral sclerosis: a long-term safety study. Cytotherapy 14, 56-60.
74. McGill, T.J., Cottam, B., Lu, B., Wang, S., Girman, S., Tian, C., Huhn, S.L., Lund, R.D., and Capela, A. (2012). Transplantation of human central nervous system stem cells-neuroprotection in retinal degeneration. Eur. J. Neurosci. 35, 468-477.
75. Mesoblast (2015). http://ir.mesoblast.com/investors/?page=news-announcements.
76. Mitchell, A., Fujisawa, T., Newby, D., Mills, N., and Cruden, N.L. (2015). Vascular injury and repair: a potential target for cell therapies. Future Cardiol. 11, 45-60.
77. Muroi, K., Miyamura, K., Ohashi, K., Murata, M., Eto, T., Kobayashi, N., Tani-guchi, S., Imamura, M., Ando, K., Kato, S., et al. (2013). Unrelated allogeneic bone marrow-derived mesenchymal stem cells for steroid-refractory acute graft-versus-host disease: a phase I/II study. Int. J. Hematol. 98, 206-213.
78. Murphy, S.V., Kidyoor, A., Reid, T., Atala, A., Wallace, E.M., and Lim, R. (2014). Isolation, cryopreservation and culture of human amnion epithelial cells for clinical applications. J. Vis. Exp. 94, http://dx.doi.org/10.3791/52085.
79. Nowbar, A.N., Mielewczik, M., Karavassilis, M., Dehbi, H.M., Shun-Shin, M.J., Jones, S., Howard, J.P., Cole, G.D., and Francis, D.P.; DAMASCENE writing group (2014). Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis. BMJ 348, g2688.
80. Orozco, L., Soler, R., Morera, C., Alberca, M., Sánchez, A., and García-San-cho, J. (2011). Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation 92, 822-828.
81. Orozco, L., Munar, A., Soler, R., Alberca, M., Soler, F., Huguet, M., Sentís, J., Sánchez, A., and García-Sancho, J. (2013). Treatment of knee osteoarthritis with autologous mesenchymal stem cells: a pilot study. Transplantation 95, 1535-1541.
82. Pellegrini, G., and De Luca, M. (2014). Eyes on the prize: limbal stem cells and corneal restoration. Cell Stem Cell 15, 121-122.
83. Pellegrini, G., Rama, P., Di Rocco, A., Panaras, A., and De Luca, M. (2014). Concise review: hurdles in a successful example of limbal stem cell-based regenerative medicine. Stem Cells 32, 26-34.
84. Perez-Simon, J.A., Lopez-Villar, O., Andreu, E.J., Rifon, J., Muntion, S., Diez Campelo, M., Sanchez-Guijo, F.M., Martinez, C, Valcarcel, D., and Canizo, CD. (2011). Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial. Haematologica 96, 1072-1076.
85. Prasad, V.K., Lucas, K.G., Kleiner, G.I., Talano, J.A., Jacobsohn, D., Broadwater, G., Monroy, R., and Kurtzberg, J. (2011). Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol. Blood Marrow Transplant. 17, 534-541.
86. Rama, P., Matuska, S., Paganoni, G., Spinelli, A., De Luca, M., and Pellegrini, G. (2010). Limbal stem-cell therapy and long-term corneal regeneration. N. Engl. J. Med. 363, 147-155.
87. Ratcliffe, E., Glen, K.E., Naing, M.W., and Williams, D.J. (2013). Current status and perspectives on stem cell-based therapies undergoing clinical trials for regenerative medicine: case studies. Br. Med. Bull. 108, 73-94.
88. Raval, A.N., Schmuck, E.G., Tefera, G., Leitzke, C, Ark, C.V., Hei, D., Cen-tanni, J.M., de Silva, R., Koch, J., Chappell, R.G., and Hematti, P. (2014). Bilateral administration of autologous CD133+ cells in ambulatory patients with refractory critical limb ischemia: lessons learned from a pilot randomized, double-blind, placebo-controlled trial. Cytotherapy 16, 1720-1732.
89. Reinders, M.E., de Fijter, J.W., Roelofs, H., Bajema, I.M., de Vries, D.K., Schaapherder, A.F., Claas, F.H., van Miert, P.P., Roelen, D.L., van Kooten, C, et al. (2013). Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study. Stem Cells Transl. Med. 2, 107-111.
90. Reinders, M.E., Bank, J.R., Dreyer, G.J., Roelofs, H., Heidt, S., Roelen, D.L., Al Huurman, V., Lindeman, J., van Kooten, C, Claas, F.H., et al. (2014). Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipients. J. Transl. Med. 12, 331.
91. ReNeuron (2014). http://www.reneuron.com/pisces-phase-i-clinical-trial-in-stroke-disability.
92. Rennie, K., Haukenfrers, J., Ribecco-Lutkiewicz, M., Ly, D., Jezierski, A., Smith, B., Zurakowski, B., Martina, M., Gruslin, A., and Bani-Yaghoub, M. (2013). Therapeutic potential of amniotic fluid-derived cells for treating the injured nervous system. Biochem. Cell Biol. 91, 271-286.
93. Riley, J., Federici, T., Polak, M., Kelly, C, Glass, J., Raore, B., Taub, J., Kesner, V., Feldman, E.L., and Boulis, N.M. (2012). Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery 71, 405-416, discussion 416.
94. Savitz, S.I., Chopp, M., Deans, R., Carmichael, T., Phinney, D., and Wechsler, L.; STEPS Participants (2011). Stem cell therapy as an emerging paradigm for stroke (STEPS) II. Stroke 42, 825-829.
95. Savitz, S.I., Cramer, S.C., and Wechsler, L.; STEPS 3 Consortium (2014). Stem cells as an emerging paradigm in stroke 3: enhancing the development of clinical trials. Stroke 45, 634-639.
96. Schulz, T.C., Young, H.Y., Agulnick, A.D., Babin, M.J., Baetge, E.E., Bang, A.G., Bhoumik, A., Cepa, I., Cesario, R.M., Haakmeester, C, et al. (2012). A scalable system for production of functional pancreatic progenitors from human embryonic stem cells. PLoS ONE 7, e37004.
97. Schwartz, S.D., Hubschman, J.P., Heilwell, G., Franco-Cardenas, V., Pan, C.K., Ostrick, R.M., Mickunas, E., Gay, R., Klimanskaya, I., and Lanza, R. (2012). Embryonic stem cell trials for macular degeneration: a preliminary report. Lancet 379, 713-720.
98. Schwartz, S.D., Regillo, CD., Lam, B.L., Eliott, D., Rosenfeld, P.J., Gregori, N.Z., Hubschman, J.P., Davis, J.L., Heilwell, G., Spirn, M., et al. (2015). Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies. Lancet 385, 509-516.
99. Selden, N.R., Al-Uzri, A., Huhn, S.L., Koch, T.K., Sikora, D.M., Nguyen-Driver, M.D., Guillaume, D.J., Koh, J.L., Gultekin, S.H., Anderson, J.C., et al. (2013). Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J Neurosurg. Pediatr. 11, 643-652.
100. Shizuru, J.A., Jerabek, L., Edwards, C.T., and Weissman, I.L. (1996). Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment. Biol. Blood Marrow Transplant. 2, 3-14.
101. Shortt, A.J., Bunce, C., Levis, H.J., Blows, P., Doré, C.J., Vernon, A., Secker, G.A., Tuft, S.J., and Daniels, J.T. (2014). Three-year outcomes of cultured lim-bal epithelial allografts in aniridia and Stevens-Johnson syndrome evaluated using the Clinical Outcome Assessment in Surgical Trials assessment tool. Stem Cells Transl. Med. 3, 265-275.
102. Shroff, G., Gupta, A., and Barthakur, J.K. (2014). Therapeutic potential of human embryonic stem cell transplantation in patients with cerebral palsy. J. Transl. Med. 12, 318.
103. StemCells Inc (2014). http://investor.stemcellsinc.com/phoenix.zhtml?c= 86230&p=irol-newsArticle&ID=1974747.
104. StemCells Inc (2015). http://www.stemcellsinc.com/Clinical-Programs/AMD.
105. Suncion, V.Y., Ghersin, E., Fishman, J.E., Zambrano, J.P., Karantalis, V., Man-del, N., Nelson, K.H., Gerstenblith, G., DiFede Velazquez, D.L., Breton, E., et al. (2014). Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial. Circ. Res. 114, 1292-1301.
106. Tabakow, P., Jarmundowicz, W., Czapiga, B., Fortuna, W., Miedzybrodzki, R., Czyz, M., Huber, J., Szarek, D., Okurowski, S., Szewczyk, P., et al. (2013). Transplantation of autologous olfactory ensheathing cells in complete human spinal cord injury. Cell Transplant. 22, 1591-1612.
107. Thomsen, G.M., Gowing, G., Svendsen, S., and Svendsen, C.N. (2014). The past, present and future of stem cell clinical trials for ALS. Exp. Neurol. 262 Pt B, 127-137.
108. Trounson, A., Baum, E., Gibbons, D., and Tekamp-Olson, P. (2010). Developing a case study model for successful translation of stem cell therapies. Cell Stem Cell 6, 513-516.
109. Trounson, A., Thakar, R.G., Lomax, G., and Gibbons, D. (2011). Clinical trials for stem cell therapies. BMC Med. 9, 52.
110. Turner, M., Leslie, S., Martin, N.G., Peschanski, M., Rao, M., Taylor, C.J., Trounson, A., Turner, D., Yamanaka, S., and Wilmut, I. (2013). Toward the development of a global induced pluripotent stem cell library. Cell Stem Cell 13, 382-384.
111. Wang, X.X., Zhang, F.R., Shang, Y.P., Zhu, J.H., Xie, X.D., Tao, Q.M., Zhu, J.H., and Chen, J.Z. (2007). Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J. Am. Coll. Cardiol. 49, 1566-1571.
112. Wilson, J.G., Liu, K.D., Zhuo, H., Caballero, L., McMillan, M., Fang, X., Cos-grove, K., Vojnik, R., Calfee, C.S., Lee, J.W., et al. (2015). Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial. Lancet Respir. Med. 3, 24-32.
113. Yamout, B., Hourani, R., Salti, H., Barada, W., El-Hajj, T., Al-Kutoubi, A., Her-lopian, A., Baz, E.K., Mahfouz, R., Khalil-Hamdan, R., et al. (2010). Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study. J. Neuroimmunol. 227, 185-189.
114. Yang, S.S., Kim, N.R., Park, K.B., Do, Y.S., Roh, K., Kang, K.S., and Kim, D.I. (2013). A phase I study of human cord blood-derived mesenchymal stem cell therapy in patients with peripheral arterial occlusive disease. Int. J Stem Cells 6, 37-44.
115. Zakaria, N., Possemiers, T., Dhubhghaill, S.N., Leysen, I., Rozema, J., Koppen, C., Timmermans, J.P., Berneman, Z., and Tassignon, M.J. (2014). Results of a phase I/II clinical trial: standardized, non-xenogenic, cultivated limbal stem cell transplantation. J. Transl. Med. 12, 58.